This complimentary webinar focused on deep analysis of pro and contra for clinical research in post-Soviet states, which have become the fastest-growing clinical trial markets and are known for its rapid recruitment and high data quality

01 August 2014

This complimentary webinar focused on deep analysis of pro and contra for clinical research in post-Soviet states, which have become the fastest-growing clinical trial markets and are known for its rapid recruitment and high data quality. Regulatory processes, timelines and enrollment forecasts were presented as well as strategies for involving each country in clinical study rescue were also be discussed.

In this webinar Cromos Pharma's management presented comprehensive SWOT analysis for each of the following countries: Belarus, Georgia, Russia, Ukraine and the Baltic states.

Please follow links to webinar video and to download slides.

Key Learning Objectives:

  • Strengths, Weaknesses, Opportunities and Threats for clinical trial conduct in each of the aforementioned countries
  • Regulatory environments
  • Realistic timelines for country start-up
  • Enrollment potential in key therapeutic areas

Presenters:

Vladimir Bogin, CEO at Cromos Pharma, LLC

Vladimir Krechikov, Director of Business Development at Cromos Pharma, LLC

Andrii Paliichuk, Country Head at Cromos Pharma Ukraine, LLC

Irina Murashko, Country Specialist at Cromos Pharma Belarus, LLC

Tsira Jibladze, Country Head at Cromos Pharma Georgia, LLC

Back to the events